Stand Up To Cancer - standuptocancer.orgThis is where the end of cancer begins
   Please leave this field empty

In The News

Share this:

Like this page on Facebook

Cancer Taught Me to Live My Best Life

Tamara Wallace Norman describes her journey with breast cancer as something that caused her to become a more authentic version of herself.

+ More

SU2C-American Cancer Society Lung Cancer Dream Team discover new strategy in treating patients

Dr. Janne and the SU2C-American Cancer Society Lung Cancer Dream Team have been focused on treating lung cancer patients with mutant KRAS. In this new publication, they report that a subgroup of patients with mutant KRAS may benefit from drugs called MEK inhibitors, if these patients do not have as much of the non-mutant KRAS protein. This information is helpful in deciding what treatments can be used for certain patients with mutant KRAS.

+ More

Scientists map genomes of brain tumors in search of targets for drug treatment

Scientists with the SU2C-St. Baldrick’s Foundation Pediatric Cancer Dream Team mapped out the genetic landscape of selected ependymomas to find targets for treatment and reported encouraging preliminary data on the identification of drugs that could have an impact on the tumors.

+ More

Emily Whitehead is named one of the “10 people who mattered this year” by Nature

Emily Whitehead, the little girl who was first person ever to receive the CAR-T treatment for leukemia, has been named one of the “ten people who mattered this year” by Nature, the world’s most influential journal of multidisciplinary science, marking FDA approval of the treatment, supported by SU2C research.

+ More

Bernstein featured amongst Three Women Breaking New Ground in Research

Kara Bernstein, PhD, recipient of a 2016 Innovative Research Grant (IRG) from SU2C, is featured in a story on "Meet Three Women Breaking New Ground in Research" in the Media Planet supplement to USA TODAY on Education and Career News. Dr. Bernstein is at the University of Pittsburgh. She is using her IRG to study factors affecting predisposition to cancer.

+ More

Innovate Collaborate Accelerate